Top Buy
| Wertpapier | Buy ▼ | Sell | Buy (1M) | Sell (1M) | Kurs | Kursziel | Potential |
|---|---|---|---|---|---|---|---|
| Eli Lilly Corp. | 68 | 0 | 9 | 0 | 867,80 € | 883,50 € | 1,81 % |
| Vertex Pharmaceuticals Inc. | 58 | 2 | 7 | 0 | 448,50 € | 450,36 € | 0,42 % |
| Biogen Inc. | 51 | 2 | 5 | 1 | 185,20 € | 284,87 € | 53,82 % |
| Insmed Inc. | 47 | 0 | 7 | 0 | 68,50 € | 77,59 € | 13,27 % |
| Regeneron Pharmaceuticals Inc. | 47 | 1 | 9 | 0 | 1.072,0 € | 1.091,9 € | 1,86 % |
| Alnylam Pharmace. | 46 | 1 | 8 | 1 | 237,70 € | 271,50 € | 14,22 % |
| Neurocrine Bioscience | 45 | 0 | 10 | 0 | 115,00 € | 149,74 € | 30,21 % |
| Johnson & Johnson | 40 | 1 | 2 | 0 | 150,02 € | 187,62 € | 25,06 % |
| Acadia Pharmaceuticals | 35 | 1 | 7 | 0 | 14,13 € | 29,92 € | 111,79 % |
| AbbVie Inc. | 34 | 0 | 3 | 0 | 177,58 € | 181,45 € | 2,18 % |
| Merck & Co. Inc. | 33 | 1 | 5 | 0 | 107,20 € | 125,91 € | 17,45 % |
| Pfizer Inc. | 32 | 4 | 7 | 0 | 26,24 € | 41,49 € | 58,16 % |
| Intra-Cellular Therapies Inc. | 31 | 0 | 3 | 0 | 66,50 € | 84,73 € | 27,41 % |
| Cytokinetics Inc. | 30 | 1 | 1 | 0 | 52,00 € | 84,53 € | 62,56 % |
| Ionis Pharmaceuticals Inc. | 28 | 6 | 2 | 1 | 43,12 € | 56,72 € | 31,54 % |
| Amgen Inc. | 28 | 0 | 3 | 0 | 301,95 € | 304,82 € | 0,95 % |
| United Therapeutics | 27 | 1 | 5 | 1 | 329,00 € | 341,51 € | 3,80 % |
| Ultragenyx Pharmaceutical Inc. | 25 | 1 | 4 | 0 | 51,00 € | 84,74 € | 66,16 % |
| Zoetis Inc. A | 25 | 1 | 4 | 0 | 166,00 € | 198,11 € | 19,34 % |
| BioMarin Pharmaceutical Inc. | 23 | 0 | 7 | 0 | 82,52 € | 102,48 € | 24,18 % |
| Halozyme Therapeutics Inc. | 23 | 0 | 5 | 0 | 57,76 € | 56,00 € | -3,05 % |
| Sutro Biopharma Inc | 21 | 0 | 2 | 0 | 4,06 € | 11,04 € | 171,98 % |
| Exelixis Inc. | 21 | 0 | 2 | 0 | 23,23 € | 26,01 € | 11,95 % |
| EyePoint Pharmaceuticals Inc. | 21 | 1 | 2 | 0 | 7,93 € | 27,91 € | 251,90 % |
| Krystal Biotech | 20 | 0 | 4 | 0 | 176,40 € | 185,58 € | 5,20 % |